500 related articles for article (PubMed ID: 21810607)
21. Apolipoprotein E and its mimetic peptide suppress Th1 and Th17 responses in experimental autoimmune encephalomyelitis.
Wei J; Zheng M; Liang P; Wei Y; Yin X; Tang Y; Xue Y
Neurobiol Dis; 2013 Aug; 56():59-65. PubMed ID: 23619428
[TBL] [Abstract][Full Text] [Related]
22. 4-Ethylguaiacol modulates neuroinflammation and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis.
Weng WT; Kuo PC; Brown DA; Scofield BA; Furnas D; Paraiso HC; Wang PY; Yu IC; Yen JH
J Neuroinflammation; 2021 May; 18(1):110. PubMed ID: 33975618
[TBL] [Abstract][Full Text] [Related]
23. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration.
de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP
Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850
[TBL] [Abstract][Full Text] [Related]
24. Invariant NKT cells producing IL-4 or IL-10, but not IFN-gamma, inhibit the Th1 response in experimental autoimmune encephalomyelitis, whereas none of these cells inhibits the Th17 response.
Oh SJ; Chung DH
J Immunol; 2011 Jun; 186(12):6815-21. PubMed ID: 21572032
[TBL] [Abstract][Full Text] [Related]
25. A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis.
Offner H; Polanczyk M
Ann N Y Acad Sci; 2006 Nov; 1089():343-72. PubMed ID: 17261780
[TBL] [Abstract][Full Text] [Related]
26. Dual effects of TRAIL in suppression of autoimmunity: the inhibition of Th1 cells and the promotion of regulatory T cells.
Ikeda T; Hirata S; Fukushima S; Matsunaga Y; Ito T; Uchino M; Nishimura Y; Senju S
J Immunol; 2010 Nov; 185(9):5259-67. PubMed ID: 20921531
[TBL] [Abstract][Full Text] [Related]
27. Pathogenic and protective functions of TNF in neuroinflammation are defined by its expression in T lymphocytes and myeloid cells.
Kruglov AA; Lampropoulou V; Fillatreau S; Nedospasov SA
J Immunol; 2011 Dec; 187(11):5660-70. PubMed ID: 22058414
[TBL] [Abstract][Full Text] [Related]
28. Estrogen inhibition of EAE involves effects on dendritic cell function.
Liu HY; Buenafe AC; Matejuk A; Ito A; Zamora A; Dwyer J; Vandenbark AA; Offner H
J Neurosci Res; 2002 Oct; 70(2):238-48. PubMed ID: 12271473
[TBL] [Abstract][Full Text] [Related]
29. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
[TBL] [Abstract][Full Text] [Related]
30. Dehydrodiconiferyl alcohol (DHCA) modulates the differentiation of Th17 and Th1 cells and suppresses experimental autoimmune encephalomyelitis.
Lee J; Choi J; Lee W; Ko K; Kim S
Mol Immunol; 2015 Dec; 68(2 Pt B):434-44. PubMed ID: 26477735
[TBL] [Abstract][Full Text] [Related]
31. Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE.
Isaksson M; Lundgren BA; Ahlgren KM; Kämpe O; Lobell A
Eur J Immunol; 2012 Oct; 42(10):2555-63. PubMed ID: 22806332
[TBL] [Abstract][Full Text] [Related]
32. The flavonoid kurarinone inhibits clinical progression of EAE through inhibiting Th1 and Th17 cell differentiation and proliferation.
Xie L; Gong W; Chen J; Xie HW; Wang M; Yin XP; Wu W
Int Immunopharmacol; 2018 Sep; 62():227-236. PubMed ID: 30031314
[TBL] [Abstract][Full Text] [Related]
33. Low dose CP-690,550 (tofacitinib), a pan-JAK inhibitor, accelerates the onset of experimental autoimmune encephalomyelitis by potentiating Th17 differentiation.
Yoshida H; Kimura A; Fukaya T; Sekiya T; Morita R; Shichita T; Inoue H; Yoshimura A
Biochem Biophys Res Commun; 2012 Feb; 418(2):234-40. PubMed ID: 22252297
[TBL] [Abstract][Full Text] [Related]
34. Green tea EGCG, T cells, and T cell-mediated autoimmune diseases.
Wu D; Wang J; Pae M; Meydani SN
Mol Aspects Med; 2012 Feb; 33(1):107-18. PubMed ID: 22020144
[TBL] [Abstract][Full Text] [Related]
35. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).
Yura M; Takahashi I; Serada M; Koshio T; Nakagami K; Yuki Y; Kiyono H
J Autoimmun; 2001 Aug; 17(1):17-25. PubMed ID: 11488634
[TBL] [Abstract][Full Text] [Related]
36. T lymphocytes do not directly mediate the protective effect of estrogen on experimental autoimmune encephalomyelitis.
Polanczyk MJ; Jones RE; Subramanian S; Afentoulis M; Rich C; Zakroczymski M; Cooke P; Vandenbark AA; Offner H
Am J Pathol; 2004 Dec; 165(6):2069-77. PubMed ID: 15579449
[TBL] [Abstract][Full Text] [Related]
37. Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands.
Elloso MM; Phiel K; Henderson RA; Harris HA; Adelman SJ
J Endocrinol; 2005 May; 185(2):243-52. PubMed ID: 15845917
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
Yang C; He D; Yin C; Tan J
Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284
[TBL] [Abstract][Full Text] [Related]
39. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis.
Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H
J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745
[TBL] [Abstract][Full Text] [Related]
40. TGF-beta-exposed plasmacytoid dendritic cells participate in Th17 commitment.
Bonnefoy F; Couturier M; Clauzon A; Rémy-Martin JP; Gaugler B; Tiberghien P; Chen W; Saas P; Perruche S
J Immunol; 2011 Jun; 186(11):6157-64. PubMed ID: 21518970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
